Immunohistochemical study of mucin expression in periampullary adenomyoma. 2010

Michiyo Higashi, and Masamichi Goto, and Miyuki Saitou, and Takeshi Shimizu, and Karine Rousseau, and Surinder K Batra, and Suguru Yonezawa
Department of Human Pathology, Field of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890-8544, Japan. east@m2.kufm.kagoshima-u.ac.jp

OBJECTIVE Benign tumors and tumor-like conditions in the ampullary area are uncommon, and there are extremely rare cases of adenomyoma (AM) and adenomyomatous hyperplasia (AMH). Surgical treatment is necessary if these lesions cause biliary obstruction. In addition, the differential diagnosis of AM and AMH from carcinoma is often difficult by standard endoscopic biopsy and cytopathological analysis that may show differential findings, resulting in unnecessary surgeries sometimes being performed. METHODS Immunohistochemical (IHC) analysis of periampullary AM and AMH was performed. RESULTS For both types of lesions, epithelial glandular cells (EGCs) showed diffuse expression of MUC6 and focal expression of HIK1083, mainly in the inner region, and focal expression of MUC5AC, mainly at the surface. The EGCs showed no expression of MUC1 or MUC4, both of which were identified as malignant tumor markers in our previous series of mucin expression studies in pancreatobiliary tumors. The expression of CK7, which was diffusely positive in normal periampullary mucosa, was decreased in the EGCs of AM and AMH. CONCLUSIONS A combined evaluation of IHC findings may be effective in the detection of AM and AMH, and also in distinguishing benign periampullary lesions, such as AM and AMH, from ampulla of Vater adenocarcinoma, thus avoiding excessive surgery.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009077 Mucins High molecular weight mucoproteins that protect the surface of EPITHELIAL CELLS by providing a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface. Mucin
D003135 Common Bile Duct The largest bile duct. It is formed by the junction of the CYSTIC DUCT and the COMMON HEPATIC DUCT. Choledochus,Bile Duct, Common,Common Bile Ducts,Duct, Common Bile
D003138 Common Bile Duct Neoplasms Tumor or cancer of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.
D004108 Dilatation, Pathologic The condition of an anatomical structure's being dilated beyond normal dimensions. Ectasia,Dilatation, Pathological,Dilatations, Pathologic,Dilatations, Pathological,Pathologic Dilatation,Pathologic Dilatations,Pathological Dilatation,Pathological Dilatations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Michiyo Higashi, and Masamichi Goto, and Miyuki Saitou, and Takeshi Shimizu, and Karine Rousseau, and Surinder K Batra, and Suguru Yonezawa
January 2002, Surgery today,
Michiyo Higashi, and Masamichi Goto, and Miyuki Saitou, and Takeshi Shimizu, and Karine Rousseau, and Surinder K Batra, and Suguru Yonezawa
October 1989, The American journal of gastroenterology,
Michiyo Higashi, and Masamichi Goto, and Miyuki Saitou, and Takeshi Shimizu, and Karine Rousseau, and Surinder K Batra, and Suguru Yonezawa
January 2007, Archives of pathology & laboratory medicine,
Michiyo Higashi, and Masamichi Goto, and Miyuki Saitou, and Takeshi Shimizu, and Karine Rousseau, and Surinder K Batra, and Suguru Yonezawa
July 2003, The Tokai journal of experimental and clinical medicine,
Michiyo Higashi, and Masamichi Goto, and Miyuki Saitou, and Takeshi Shimizu, and Karine Rousseau, and Surinder K Batra, and Suguru Yonezawa
December 2000, Gut,
Michiyo Higashi, and Masamichi Goto, and Miyuki Saitou, and Takeshi Shimizu, and Karine Rousseau, and Surinder K Batra, and Suguru Yonezawa
June 2013, Experimental oncology,
Michiyo Higashi, and Masamichi Goto, and Miyuki Saitou, and Takeshi Shimizu, and Karine Rousseau, and Surinder K Batra, and Suguru Yonezawa
February 2013, American journal of clinical pathology,
Michiyo Higashi, and Masamichi Goto, and Miyuki Saitou, and Takeshi Shimizu, and Karine Rousseau, and Surinder K Batra, and Suguru Yonezawa
January 2014, Journal of oral and maxillofacial pathology : JOMFP,
Michiyo Higashi, and Masamichi Goto, and Miyuki Saitou, and Takeshi Shimizu, and Karine Rousseau, and Surinder K Batra, and Suguru Yonezawa
June 1989, Tumori,
Michiyo Higashi, and Masamichi Goto, and Miyuki Saitou, and Takeshi Shimizu, and Karine Rousseau, and Surinder K Batra, and Suguru Yonezawa
October 2011, Annals of diagnostic pathology,
Copied contents to your clipboard!